CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and Non-adenoid Cystic Malignant Salivary Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00859937
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:57.015159+00:00
Published At: 2015-04-03T00:00:00+00:00
Record Updated At: 2018-04-20
Results Posted At: 2015-04-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Malignant Salivary Gland Neoplasm", "Recurrent Salivary Gland Carcinoma", "Salivary Gland Adenoid Cystic Carcinoma", "Stage IV Major Salivary Gland Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-04-20"
protocolSection.identificationModule.nctId: "NCT00859937"
protocolSection.identificationModule.officialTitle: "Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and Non-adenoid Cystic Malignant Salivary Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2015-04-03"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.